Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 19 04:00PM ET
67.91
Dollar change
+0.34
Percentage change
0.50
%
IndexS&P 500 P/E18.57 EPS (ttm)3.66 Insider Own0.13% Shs Outstand1.26B Perf Week4.73%
Market Cap85.62B Forward P/E9.92 EPS next Y6.85 Insider Trans1.39% Shs Float1.26B Perf Month3.57%
Income4.61B PEG1.36 EPS next Q1.64 Inst Own84.30% Short Float1.63% Perf Quarter37.55%
Sales372.69B P/S0.23 EPS this Y8.85% Inst Trans2.87% Short Ratio1.72 Perf Half Y16.34%
Book/sh59.97 P/B1.13 EPS next Y16.08% ROA1.78% Short Interest20.55M Perf Year-12.26%
Cash/sh8.79 P/C7.72 EPS next 5Y13.67% ROE6.07% 52W Range43.56 - 80.75 Perf YTD51.28%
Dividend Est.2.56 (3.76%) P/FCF13.53 EPS past 5Y-6.37% ROI3.06% 52W High-15.90% Beta0.57
Dividend TTM2.66 (3.92%) Quick Ratio0.60 Sales past 5Y7.79% Gross Margin13.76% 52W Low55.90% ATR (14)1.90
Dividend Ex-DateJan 23, 2025 Current Ratio0.81 EPS Y/Y TTM-43.51% Oper. Margin2.66% RSI (14)68.98 Volatility2.75% 2.87%
Employees300000 Debt/Eq1.10 Sales Y/Y TTM4.02% Profit Margin1.24% Recom1.83 Target Price72.26
Option/ShortYes / Yes LT Debt/Eq1.00 EPS Q/Q-17.61% Payout72.76% Rel Volume0.49 Prev Close67.57
Sales Surprise0.64% EPS Surprise30.25% Sales Q/Q3.77% EarningsFeb 12 BMO Avg Volume11.92M Price67.91
SMA204.11% SMA5014.67% SMA20017.24% Trades Volume5,871,417 Change0.50%
Date Action Analyst Rating Change Price Target Change
Feb-13-25Upgrade Leerink Partners Market Perform → Outperform $55 → $75
Feb-12-25Upgrade Cantor Fitzgerald Neutral → Overweight
Jan-30-25Upgrade Edward Jones Hold → Buy
Dec-03-24Upgrade Deutsche Bank Hold → Buy $66
Nov-18-24Upgrade Wells Fargo Equal Weight → Overweight $60 → $66
Oct-10-24Upgrade Barclays Equal Weight → Overweight $63 → $82
Oct-04-24Upgrade TD Cowen Hold → Buy $59 → $85
May-30-24Initiated Robert W. Baird Neutral $61
May-07-24Downgrade TD Cowen Buy → Hold $99 → $59
May-02-24Downgrade UBS Buy → Neutral $85 → $60
Today 04:21PM
04:34AM
Mar-18-25 05:03AM
Mar-16-25 07:22AM
Mar-14-25 05:30PM
11:30AM Loading…
11:30AM
06:30AM
Mar-13-25 05:45PM
11:25AM
Mar-12-25 09:00AM
Mar-11-25 11:08AM
10:12AM
Mar-10-25 05:07PM
05:09AM
Mar-09-25 08:10PM
06:07PM Loading…
06:07PM
Mar-08-25 05:30AM
Mar-06-25 05:33PM
05:33PM
05:33PM
08:30AM
Mar-05-25 05:29AM
04:22AM
Mar-04-25 12:00PM
08:09AM
08:04AM
Mar-02-25 10:47AM
Mar-01-25 06:05PM
Feb-27-25 04:23PM
09:45AM
04:11PM Loading…
Feb-26-25 04:11PM
09:00AM
Feb-21-25 06:36PM
04:54PM
02:53PM
01:22PM
Feb-20-25 02:00PM
Feb-19-25 05:23PM
05:17PM
04:55PM
04:00PM
05:28AM
Feb-18-25 09:00PM
04:51PM
04:48PM
12:15PM
04:24AM
Feb-17-25 04:21PM
09:30AM
Feb-15-25 10:06AM
Feb-14-25 09:55AM
07:03AM
Feb-13-25 06:51PM
02:46PM
01:32PM
10:17AM
09:37AM
09:14AM
08:24AM
02:08AM
12:20AM
12:04AM
Feb-12-25 04:59PM
04:59PM
04:36PM
04:29PM
04:25PM
04:06PM
01:59PM
01:54PM
01:49PM
01:15PM
01:10PM
12:01PM
11:54AM
11:54AM
11:11AM
11:05AM
10:59AM
10:30AM
10:27AM
10:24AM
09:30AM
09:10AM
08:29AM
08:23AM
08:23AM
07:48AM
07:40AM
07:04AM
06:57AM
06:55AM
06:40AM
06:37AM
06:37AM
06:30AM
Feb-11-25 07:00PM
04:30PM
02:30PM
09:03AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shah Prem SEVP and Group PresidentMar 17 '25Option Exercise62.2184652,63043,190Mar 18 04:51 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Option Exercise62.217,513467,38415,907Mar 07 04:56 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Sale66.357,513498,4888,394Mar 07 04:56 PM
Clark James DavidOfficerMar 05 '25Proposed Sale66.357,513498,489Mar 05 05:25 PM
Mahoney Michael FDirectorFeb 18 '25Buy66.7030,0002,001,00039,356Feb 19 12:35 PM
LUDWIG EDWARD JDirectorMay 02 '24Buy53.881,00053,87921,630May 02 04:31 PM
Mahoney Michael FDirectorMay 02 '24Buy54.499,181500,2949,356May 02 04:30 PM